Xiong et al. (94) reported that CASC2 is downregulated in thyroid cancer tissues, and its overexpression in vitro can inhibit the proliferation of thyroid cancer cells by interfering with the cell cycle. The gene discussed is CASC2; the disease is thyroid gland carcinoma.